INDIA: Dr. Reddy’s and Nestlé Health Science Limited, a joint venture between Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”) and Nestlé India Limited (BSE: 500790, NSE: NESTLEIND) referred hereafter as “Nestlé India”, today announced the launch of Celevida^®GLP+, a specialised scientifically designed product to support optimum nutrition intake and muscle mass maintenance for sustaining metabolic and functional health for people undergoing GLP-1/GIP therapy* for management of type 2 diabetes and obesity in India.

As GLP-1/GIP–based therapies become more widely adopted in the management of type 2 diabetes and obesity, improving access to advanced treatment options for patients, it has become increasingly important to build an integrated ecosystem beyond medication. Encompassing nutrition, clinical monitoring, and long-term patient support, this ecosystem should be an enabler for sustained and holistic outcomes for patients managing type 2 diabetes and obesity. A critical component of this approach is addressing the nutritional gaps and muscle health challenges associated with these therapies to improve overall outcomes.

M.V. Ramana, CEO, Global Generics at Dr. Reddy’s Laboratories Limited and Director, Dr. Reddy’s and Nestlé Health Science Limited, “GLP-1 therapies represent a significant advancement in diabetes and obesity management. However, a clear unmet need remains in supporting patients beyond pharmacological treatment, particularly in addressing nutrition gaps and preserving muscle health during therapy. As patients experience changes in body composition, ensuring adequate nutrient intake and maintaining lean body mass become critical to sustaining long-term outcomes. With Celevida^® GLP+, we aim to address this gap through a targeted, science-backed nutritional solution that complements pharmacological therapies and supports better overall patient outcomes in their everyday journey. As part of this commitment, we remain focused on advancing integrated, patient-centric solutions that enable more sustainable and holistic management of metabolic health.”

Insights from senior Indian clinicians highlighted a critical and often under-recognized risk: muscle loss during GLP-1/GIP therapy. Studies indicate that 25-40% of total weight loss associated with GLP-1 and dual GLP-1/GIP therapies may be attributed to lean body mass loss ^(1,2). Experts noted that this risk may be amplified in Indians due to inherently lower baseline skeletal muscle mass and higher body fat mass (3), which may be further compounded by chronically low protein intake of approximately 0.6g/kg/day⁽⁴⁾. This creates a dual vulnerability, making muscle preservation not just important, but essential for long-term metabolic health.

Clinical and expert consensus recommend increasing protein intake to 1.2–1.5 g/kg/day to help preserve muscle mass during weight loss, highlighting the need for customised nutritional support ⁽⁵⁾.

Addressing this need, Celevida^® GLP+ has been scientifically designed and co-created with leading endocrinologists and diabetologists to address protein gaps and preserve muscle mass and function in individuals undergoing GLP-1/GIP therapy. It is formulated using fast-absorbing whey protein isolate (WPI), known to be gentle on the gut and suitable during periods of gastrointestinal intolerance commonly associated with GLP-1/GIP therapy.  Celevida® GLP+ provides 48 g of protein per 100 g, along with 100% RDA (Recommended Dietary Allowance) of branched-chain amino acids (BCAAs). It also provides 27 essential nutrients, including vitamins A, D, and calcium. Dr. Reddy’s and Nestlé Health Science have an established presence in specialised nutrition for people with diabetes through its Celevida^® Diabetes Nutrition, designed to support comprehensive diabetes management. The formulation is clinically proven to support sustained 24-hour blood glucose control and reduce HbA1c levels (6), and is characterised by a low glycaemic index⁽⁷⁾, making it suitable for long-term metabolic management.

Celevida^® GLP+ is available in a 350 g pack across pharmacies, retail outlets, and leading e-commerce platforms.

The post Dr. Reddy’s and Nestlé Health Science Collaborate to Launch Celevida® GLP+ appeared first on NRI News.

BENGALURU: Taking a major initiative towards expert liver care, Aster Whitefield Hospital has declared the launch of the first dedicated Liver Intensive Care Unit (ICU) in Karnataka. This is a state-of-the-art facility designed only for liver failure patients, those having biliary problems, and liver transplant cases. The ICU, named SHIELD (Specialized Hepatic Intensive & Emergency Liver Division), is a state-of-the-art facility designed solely for patients with liver failure, biliary problems, and liver transplant cases. Setting the Liver-specific ICU as a real rescue for patients in critical condition, it is a confluence of renowned doctors, modern facilities, and continuous patient monitoring to provide highly specialised, multi-disciplinary care aimed at improving patient outcomes. Through this, Aster has once again shown its desire to promote islands of excellence aimed at quaternary single-organ care pathways for better results for patients with complicated liver diseases. The programme was honoured by the presence of Dr. C. N. Manjunath, Hon’ble Member of Parliament (Lok Sabha), as the Chief Guest.

Speaking ahead of the inauguration, Dr. C. N. Manjunath said, “Liver problems are turning out to be a sneaky but major health issue in India, and usually, it’s at a very severe stage when the patients are found. A liver ICU dedicated to liver care opening at Aster Whitefield Hospital is a very appropriate and great step that will enable our healthcare system to be more efficient and quicker in handling very difficult liver cases. Apart from better survival chances, specialized facilities equip the patient care to be comprehensive and in collaboration with various medical disciplines.”

Adding to this, Dr. H R S Girn, Senior Consultant – HPB and Liver Transplant surgeon, Aster Whitefield Hospital, said: “The establishment of a specialty Liver ICU represents an innovative approach in the establishment of a single point care facility for liver sick patients requiring what we call the Liver Arc services (Hepatology, ICU, Surgery, Transplantation, Luminal and radiological interventions) under one roof. A person with decompensated cirrhosis or liver failure experiences rapid changes within a short period of time. Thus, in this case, having a speciality dedicated ICU implies that all actions can be taken efficiently and effectively for the patients and their families. In turn, this provides a seamless referral and healthcare delivery pathway aimed at holistic liver care, liver-specific training for budding future specialists, and brings liver care at par with other resource-intensive single-organ dedicated ICUs like the Cardiac or Neuro ICUs, which have traditionally been the norm.  With busy lives, nuclear families, and increasing liver disease burden in the country, single organ-specific facilities under trusted brands like Aster are the need of the hour as a single point of contact resource for the patients suffering from life-threatening conditions.”

Srikant Subudhi, Chief Operating Officer, Aster Whitefield Hospital, added: “At Aster Whitefield Hospital, the core of our efforts is the creation of highly sophisticated, patient-oriented healthcare ecosystems that can effectively meet the various clinical needs of today and tomorrow. The launching of Karnataka’s first dedicated Liver ICU is a powerful indication of how we are always ready to put our money into the specialised infrastructure which is capable of dealing with the increasing complexity of liver-related diseases. Not only does this facility leverage state-of-the-art technology and a wide range of medical experts, but it also ensures continuous monitoring for better clinical results and provides easier access to specialised and high-quality treatment.“

The Liver ICU will be a collaborative endeavor by a team of highly skilled and proficient physicians, including liver transplantation surgeons, hepatologists, and gastroenterologists, as well as critical care specialists. This dedicated unit will try to fill a major void in the liver care infrastructure of Karnataka, and it will be a one-stop solution for patients to get timely, cutting-edge, and life-saving treatment.

The post Aster Whitefield Hospital Unveils Karnataka’s First Dedicated Liver ICU appeared first on NRI News.

The patient was admitted to the Critical Care Unit (CCU) at Inamdar Multispeciality Hospital on 1/3/26 under Dr. Amit Mazumdar with a sudden onset of breathlessness and severe oxygen desaturation following the consumption of outside food. She was a high-risk case, with multiple co-morbidities including morbid obesity, diabetes, and multinodular toxic goiter, and was also diagnosed with pneumothorax.

Initial Management (Date: 4/3/26)

An intercostal drainage (ICD) tube was inserted to manage the pneumothorax. The patient was stabilised and maintained on ventilatory support, with a trial on T-piece conducted after initial improvement.

Failed Extubation Attempts (Dates: 5/3/26 / __)

Despite meeting extubation parameters, two separate attempts to wean her off ventilatory support failed due to persistent desaturation, necessitating re-intubation. The inability to sustain spontaneous breathing raised the need for a definitive airway solution.

At this stage, the treating team explained the need for tracheostomy and thyroidectomy to the family. Given the perceived risks associated with thyroid surgery, the relatives initially consented only to tracheostomy, which was considered semi-urgent.

Intraoperative Turning Point (Date of Surgery: 9/3/26)

During surgery at Inamdar Multispeciality Hospital, doctors encountered a critical anatomical challenge. The patient had a massively enlarged thyroid gland extending retrosternally and completely engulfing the trachea, making tracheostomy technically impossible without first removing the thyroid.

This intraoperative finding necessitated an immediate change in surgical plan. The patient’s relatives were counselled again in real time regarding the urgency and inevitability of proceeding with thyroidectomy.

The surgery was led by Dr. Pravin Bhosale, ENT Surgeon, with support from the general surgery team—Dr. Nelson and Dr. Abhijeet Gotkhinde, while the anaesthesia team comprising Dr. Sandeep Patil and Dr. Jyoti Sawant ensured stable intraoperative management.

Following thyroid removal, the team conducted critical intraoperative assessments. The integrity of both recurrent laryngeal nerves was confirmed, the parathyroid glands were preserved, and there was no evidence of tracheomalacia.

Critical Surgical Decision

Based on these findings, the team made a decisive call to avoid tracheostomy and attempt controlled extubation.

Dr. Pravin Bhosale, ENT Surgeon, said, “This was a highly critical case because what appeared to be a routine need for tracheostomy turned into a complex airway emergency inside the operating theatre. The thyroid was massively enlarged and retrosternal, completely engulfing the trachea, leaving no safe option except to change the surgical plan immediately. In such situations, precise judgment, timing, and coordinated teamwork are absolutely crucial to achieving a successful outcome.”

Post-Operative Recovery (Date: 10/3/26)

The patient’s recovery was notably rapid. She required only two days of CCU care post-surgery. Swallowing function was assessed using bedside FEES (Functional Endoscopic Evaluation of Swallowing), following which all supportive lines and tubes, including Ryle’s tube, catheter, and surgical drains, were removed in a phased manner.

Discharge and Outcome (Date of Discharge: 14/3/26)

The patient was discharged in stable condition, marking a successful outcome in what doctors at Inamdar Multispeciality Hospital describe as a rare convergence of airway compromise and endocrine pathology.

Reflecting on her experience, the patient said, “I was struggling to breathe, and it was a very difficult time for my family and me. The doctors explained every step and gave us confidence throughout. I feel grateful to have recovered and to be going home.”

The case involved a multidisciplinary effort, with contributions from Dr. Mulla (Endocrinologist), Dr. Ajinkya Gulave, and Dr. Vrushali (Pulmonologists), along with ICU teams, operation theatre staff, and hospital support departments.

Clinical Significance

Doctors involved in the case emphasised that such outcomes depend heavily on real-time intraoperative judgment, multidisciplinary coordination, and the ability to adapt surgical strategy based on evolving clinical findings.

The post A High-Risk Thyroid Case and the Impact of Airway Access Failure on Surgical Decisions appeared first on NRI News.

As part of the camp, Shanti Clinic will offer an all-inclusive cataract surgery package at ₹9,999. The package is designed to provide transparent, accessible, and high-quality care to a wider group of patients. The surgery is performed by experienced surgeons, using advanced equipment and high-quality intraocular lenses (IOLs).

Individuals experiencing symptoms such as blurred vision, glare, or difficulty in daily activities are encouraged to visit during the camp period for screening and guidance on treatment options.

Shanti Clinic is a diagnostic and healthcare centre operated by the Sadhu Vaswani Mission. The clinic offers consultations, diagnostic services, and an in-house optical shop, Bright Eyes.

For registrations, please contact: Dr Pooja Patel, Counsellor on 9168013322.

Address: Shanti Clinic 9, Sadhu Vaswani Rd, opposite Sadhu Vaswani Mission, Agarkar Nagar, Pune 411001.

Clinic timings: 9.30 am to 6.30 pm.

The post Shanti Clinic Launches Affordable Cataract Camp appeared first on NRI News.

The initiative comes at a time when obesity is increasingly recognized as a medical condition rather than merely a lifestyle issue. Recently, obesity has been formally classified as a disease in international medical coding systems (ICD), enabling structured treatment approaches including medical therapies and advanced bariatric procedures.

Mr.Naval Kishor Ram, Commissioner, Pune Municipal Corporation, said that there is a lack of awareness about Non-Communicable Diseases (NCDs)  in people. We inculcate the importance of early and proper diagnosis. Commending the initiative, he said that through this centre, Noble Hospital has taken a very important step to address the very root of obesity.

One of its kind, an integrated and comprehensive centre for obesity 

This is one of its kind centres for the management of obesity with a holistic approach through integrated and comprehensive care for all kinds of obesity for adults as well as small children. Individuals seeking medical advice for obesity are guided by an obesity management group comprising a multidisciplinary team, right from a physician to a surgeon to a psychologist, delivering world-class non-surgical as well as surgical treatment regulated by international standards.

The new centre will offer integrated care through a multidisciplinary team, including bariatric medicine physicians, bariatric surgeon specialists, cosmetic-plastic surgeons, obesity and metabolic health nutritionists, bariatric physiotherapists, obesity educators, and dedicated counsellors. 

The facility will provide advanced diagnostic and therapeutic options such as advanced body composition analysis, DEXA scan unit, modern bariatric surgery infrastructure like robotics, and Non-invasive weight-loss procedures like the Allurion endoscopic gastric balloon.

Being the pioneers in novel injectable medical therapies for weight loss, the hospital will integrate its experienced Bariatric physician team in this center of excellence.

To complete the transformation process, body contouring, including suitable surgical or non-surgical procedures designed to remove excess, sagging skin and stubborn fat deposits following weight loss, will also be available under one roof. The facility will also house an advanced bariatric operating table for enhanced patient safety.

The multidisciplinary team includes Dr. Reema Kashiva, Bariatric Physician, Dr. Parmeshwar Bambrule, Bariatric Surgeon, Dr. Ravi Swaminathan, Plastic Surgeon, Dr. Sarika Satav, Bariatric Clinical Nutritionist, Dt. Akshay Pawar, Dietician, Dr. Reshma Kangude-Lifestyle Educator, Dr. Bhupendra Gupta, Physiotherapist, Dr.Suhas Khaire, Endocrinologist, and Dr. Sheetal Harpale, Clinical Psychologist.

Dr. Reema Kashiva, Programme Director – Centre of Excellence for Obesity, Metabolic Diseases and Advanced Bariatric Sciences at Noble Hospitals, said that untreated obesity is associated with a lot of health complications, including diabetes, hypertension, heart disease, metabolic disorders, and many other diseases. Early and scientific intervention can significantly reduce these risks and improve quality of life.

Obesity needs to be addressed at its roots, with scientific management at each stage

According to the team at the centre, “For years, we were treating the complications of obesity rather than the disease itself. With the recognition of obesity as a medical condition and the availability of effective therapies, it is now possible to intervene early and prevent associated complications. People need guidance at every stage of weight management. Scientific, supervised, and team-based management of obesity is the need of the hour.”

While people have apprehensions about the side effects of medications, most of these can be tackled when taken under medical supervision. What should be considered is the risk of having weight versus the benefit of using injectable medicines to reduce weight and live a better quality of life in the future, and aiming to reduce the future complications of obesity.

The centre aims to create greater public awareness about obesity as a treatable disease and create awareness amongst people with a BMI above 30, or above 27 with comorbid conditions, to seek timely medical consultation.

Dr. Sanjay Pathare, Group Executive Officer, Noble Hospitals and Research Center, said that  “Obesity today is increasingly driven by poor dietary habits, over-nutrition, sedentary lifestyles, and stress, not just in adults but also in small children, and early and effective obesity management can significantly reduce the risk of multiple chronic diseases.“

Dr. Divij Mane, Deputy  Managing Director, Noble Hospitals, said, “Not every obese patient needs surgery. In a center of excellence, precise BMI, BCA, and comorbidity assessment is done. Non-surgical options are primarily considered. Risks such as Type 2 Diabetes, Obstructive Sleep Apnea, hypertension, and heart disease are proactively evaluated, and appropriate treatment is made available under one roof. We aim to ensure the right care plan from the right team of experts reaches every individual, from the treatment phase to follow-up care to ensure long-term well-being.”

With this integrated super-specialist team approach, Noble Hospitals seeks to strengthen its commitment to advanced metabolic care and preventive healthcare for patients in Pune and across the region.

Dr. Dileep Mane, Chairman and Managing Director, Noble Hospitals, said that “Obesity is a complex, multi-faceted disease; hence, instead of multiple standalone consults, when a dedicated team of experts jointly provides an integrated care plan tailored to each individual’s needs, you get effective and more sustainable outcomes.“

Through this Centre for Obesity, Metabolic Diseases and Advanced Bariatric Sciences, we aim to redefine obesity care with integrated treatment, advanced technology, and sustained patient support

The post Noble Hospital Unveils Centre of Excellence for Obesity and Metabolic Diseases appeared first on NRI News.

Apollo Hospitals Pune’s Oncology Centre of Excellence offers comprehensive cancer care supported by state-of-the-art technology and multidisciplinary expertise. The centre is equipped with AI-enabled PET-CT for highly accurate early detection, the VARIAN EDGE LINAC for precise, targeted radiation therapy, and the Da Vinci Xi robotic system for complex cancer surgeries across urological, gynaecological, gastrointestinal, and head and neck cancers. Backed by advanced diagnostics, precision radiation, and robotic surgery, the centre delivers an integrated approach spanning early detection, accurate diagnosis, advanced treatment, and improved recovery, reinforcing Apollo’s commitment to improving cancer outcomes through technology-led, patient-centric care.

Speaking on the launch, Dr. Manisha Karmarkar, CEO, Apollo Hospitals Pune, said, “Early cancer detection and prevention are among the most powerful tools in the fight against cancer. Early intervention significantly improves survival and reinforces Apollo’s long-standing belief that cancer can be defeated. However, screening only works when people participate. Fear, stigma, misinformation, and lack of awareness often delay diagnosis. At Apollo Hospitals Pune, our comprehensive ProHealth programme, India’s first AI-powered preventive health programme, empowers individuals to take proactive control of their health through advanced screening and risk assessment.” 

Dr. Snita Sinukumar, Senior Surgical Oncologist, Robotic and HIPEC Specialist, said, “Nearly 40 to 50% of cancers can be prevented or detected early through screening and lifestyle measures. Tests such as digital mammography, Pap smear, low-dose CT scans, colonoscopy, PSA testing, and oral examinations can identify cancer even before symptoms appear. When detected early, survival rates can improve to as high as 80 to 90% or more.” 

The Oncology Team at Apollo Hospital, Pune, further added, “Many cancers can be prevented through lifestyle choices and public health efforts. Avoiding tobacco, limiting alcohol, maintaining a healthy weight, staying active, eating fruits and vegetables, sun protection, and vaccines like HPV and Hepatitis B are key. Governments should ensure access to screening and health campaigns, while healthcare, schools, and workplaces promote healthy habits and provide guidance at an early age.”

Equally important is recognising early warning signs and overcoming the tendency to delay medical check-ups, a trend particularly common in men’s health. Symptoms such as unexplained weight loss, persistent fatigue, unusual bleeding, new lumps, or a chronic cough lasting more than three weeks should never be ignored. While these signs do not always indicate cancer, early detection is critical for successful treatment, especially for prostate, kidney, and bladder cancers, which may be asymptomatic in their early stages. Modern interventions, such as advanced robotic surgery, have made many early-stage cancers highly treatable or even completely curable. Therefore, it is essential to listen to your body, use simple screening tests such as the PSA blood test, and consult a doctor promptly if any symptoms persist. 

Through initiatives such as ‘Zero to Hero’, Apollo Hospitals Pune aims to build greater awareness, encourage proactive health-seeking behaviour, and empower individuals to take timely action, reinforcing its ongoing commitment to improving cancer outcomes through early detection and advanced care.

The post Apollo Hospitals Pune Launches ‘Zero to Hero’ Initiative appeared first on NRI News.

The launch ceremony also includes a blessing of the Home Medicare service and its dedicated mobile van by Rev. Fr. Nigel Barrett, Parish Priest of St. Andrew’s Church, marking the beginning of a new chapter in community-centred healthcare delivery.

Home Medicare is a comprehensive home-based healthcare service that offers a range of medical and supportive care solutions, including doctor visits, nursing visits, physiotherapy, ​home sample collection, and medicine delivery, allowing patients to receive professional medical support without the need for frequent hospital visits.

Dr. Russell Pinto adds, “Many patients today require ongoing medical attention but prefer to recover in the comfort of their homes. Home Medicare bridges this gap by providing hospital-grade care outside hospital walls, without compromising on quality, safety, or professional oversight.”

​Home Medicare is provided exclusively to homebound patients. With trained medical professionals and a dedicated mobile unit, Home Medicare ensures timely, efficient, and patient-centric care.

Event Details:

Event: Launch of Home Medicare Services
Date: 11th February 2026
Time: 9:30 AM
Venue: Holy Family Hospital, Front Garden, Bandra West
Inaugurated by: Dr. Russell Pinto, Honorary Consultant, MBBS, MS (General Surgery), FMAS

Services Offered under Home Medicare:

• Doctor’s visit for personalized consultations
• Nursing care for recovery and ongoing support
• Physiotherapy services
• Home sample collection
• Medicine Delivery

The launch of Home Medicare marks a significant step in Holy Family Hospital’s commitment to making quality healthcare more accessible, personalised, and patient-friendly, especially for those who need continuous medical support beyond hospital premises.

The post Dr. Russell Pinto Launches Innovative ‘Home Medicare’ Program at Holy Family Hospital appeared first on NRI News.

Imagine a garden where some seeds sprout overnight, while others remain beneath the soil, waiting for the right conditions to bloom. In child development, we often hear the phrase “wait and watch,” but for a child facing neurodivergent challenges, waiting can mean missing the most critical growth window. Early Intervention is that “right condition”, it is the specialized sunlight and soil that allows a child to flourish. At Walnut Child Development Clinic, we don’t just wait for milestones; we create the neurological pathways that make them possible. Whether it is a child with Autism finding their first words or a toddler with ADHD learning to navigate a sensory-heavy world, our mission is to turn “I can’t” into “I did.”

The Science of “Now”
The human brain undergoes its most rapid period of development between birth and age 5. During this window, neuroplasticity, the brain’s ability to form new neural connections, is at its peak. Early Intervention is not just about “catching up”; it is about clinical precision. By addressing concerns like primitive reflex integration, communication, social pragmatics, sensory processing, and motor planning early on, we can literally reshape a child’s developmental trajectory.

At Walnut Clinic, our approach moves beyond traditional therapy. We look at the “whole child.” For instance, a child struggling with attention in school might actually be dealing with underlying postural insecurities or unintegrated reflexes. By addressing the root physiological cause, we unlock their ability to learn and engage.

A Holistic Ecosystem of Care
True transformation requires more than a single perspective, which is why Walnut Clinic operates as a multidisciplinary sanctuary. Under the expert guidance of Dr. Chanchal Agrawal and Mrs. Deepali Maheshwari, our team works in a seamless loop of communication. We understand that a child isn’t a collection of isolated symptoms; they are a complex, blooming individual. To support this, we offer a comprehensive range of evidence-based treatments:

• Occupational Therapy: Improving sensory processing, fine motor skills, and independence in daily activities.
• Speech and Language Therapy: Bridging communication gaps for both verbal and non-verbal children.
• Pediatric Physiotherapy: Enhancing functional strength, posture, and gross motor milestones.
• Applied Behavior Analysis (ABA) and Behavioral Support: Utilizing structured strategies to manage social transitions and school-based behaviors.
• Special Education: Tailoring learning techniques to meet the unique cognitive needs of every learner.
• Group therapy: To enhance child social development ( Pragmatics)

A 360-Degree Support System for Families
We firmly believe that a child’s progress shouldn’t be confined to a 45-minute therapy session. This is why Walnut Clinic is a pioneer in building a supportive ecosystem that extends far beyond the therapy room. We don’t just treat children; we empower entire families through our dedicated community initiatives.
We also host free parental support groups that serve as a safe space for families to connect, share experiences, and learn strategies for navigating challenges.
Furthermore, we believe that the right tools make all the difference in home-based progress. The Walnut Store offers a curated selection of therapeutic toys, sensory tools, and educational aids specifically chosen by our experts to complement your child’s clinical goals. This ensures that the progress made at our clinic continues seamlessly within the comfort of your home.

Conclusion: Empowering the Journey Ahead
The true measure of early intervention is not found in a single session, but in the long-term confidence a child carries into the world. It is about ensuring that every child, regardless of their starting point, has the tools to navigate life with independence and joy. At Walnut Child Development Clinic, we see our role as more than just therapists; we are partners in your child’s growth. By bridging the gap between clinical expertise and a supportive community through our workshops, store, and support groups, we strive to make the developmental journey one of hope and celebration rather than stress. Your child’s potential is a story waiting to be written, and we are here to provide the support needed to make every chapter a success.

The post The Significant Impact of Early Intervention on Lives at Walnut Clinic appeared first on NRI News.

The facility was inaugurated by the leadership of Ruby Hall Clinic, including Dr. P.K. Grant, Dr. Simon Grant, and Dr. Himesh Gandhi, alongside the Kalyani family, represented by Dr. Baba Kalyani, Mrs. Sunita Kalyani, and Mr. Amit Kalyani of Bharat Forge. They were joined by international experts from Focal One, including Prof. Pascal (University of Toulouse), Dr. Damian, Vice President and CEO, and Mr. Ryan. The initiative has been made possible by the support of the Kalyani family, who have contributed to establishing the Kalyani Institute of Robotic HIFU Therapy at Ruby Hall Clinic, to improve access to advanced cancer care in India.

With over 40,000 new cases of prostate cancer diagnosed annually in India, many men traditionally delay treatment due to the risks associated with invasive surgery or radiation – specifically concerns regarding recovery time and long-term functional health.
Robotic HIFU addresses these fears by offering:
• Targeted Precision: Destroys cancerous tissue while sparing surrounding healthy structures.
• Non-Invasive Nature: A completely incision-free and radiation-free procedure.
• Rapid Recovery: Typically performed as a day-case, allowing patients to return to their lives almost immediately.
• Preserved Quality of Life: Significantly reduces the risk of urinary and sexual dysfunction compared to traditional methods.

Speaking at the launch, Dr. P.K. Grant, Chairman and Managing Trustee of Ruby Hall Clinic, said, “The introduction of the Indian subcontinent’s first Robotic HIFU therapy at Ruby Hall Clinic marks an important milestone for cancer care in our region. Our commitment has always been to bring advanced and meaningful medical technology to patients in India rather than wait for it to reach us years later. Establishing this programme reflects that philosophy and ensures that our patients have access to treatment options that prioritise both outcomes and quality of life.”

Dr Baba Kalyani, Chairman and Managing Director Bharat Forge, whose family’s philanthropic support made the institute possible, emphasised the importance of local access: “I have always believed that advances in technology should be used for the good of society. This programme is a clear example of how digital and AI-enabled innovation can make a real difference to patients by offering precise, minimally invasive treatment. Under the leadership of Dr Himesh Gandhi, the Robotic HIFU system has already begun delivering encouraging results for patients. I would like to congratulate Dr Purvez Grant and his team for making it possible for us to bring this technology to society.”

Dr Simon Grant, Physician and Trustee, Ruby Hall Clinic, noted, “FOCAL ONE offers a level of precision that allows us to treat only the areas affected by cancer with the intention of maintaining functional outcomes. We assess that cancer control can be achieved while preserving day-to-day quality of life for patients.”

Ms. Natalie Grant Nanda Ruby Hall Clinic, SPL, “Bringing the Indian subcontinent’s first Robotic HIFU therapy to Pune continues that legacy while setting the foundation for the next generation of cancer care. We are honoured to have the support of the Kalyani family in making this possible.”

From a clinical perspective Dr Himesh Gandhi, Consultant Uro-oncologist and Director of Robotic Surgery at Ruby Hall Clinic, said, “For many men, the fear of the treatment is as great as the fear of the cancer itself. Robotic HIFU removes that barrier, offering a non-invasive pathway that prioritises the patient’s functional independence and quick return to daily life.”

With the establishment of the Kalyani Institute of Robotic HIFU Therapy, Ruby Hall Clinic strengthens its position as a leader in advanced oncological care with an emphasis on accessibility, clinical excellence, and improved patient experience.

The post Ruby Hall Clinic in Pune Launches Groundbreaking Robotic HIFU Therapy for Enhanced Patient Care appeared first on NRI News.

This case stands out not only because of its rarity but also because it exemplifies high-level teamwork, rapid preparedness, and best medical practices across multiple specialties.

Antenatal Detection and High-Risk Admission

On 15/11/2025, a 28-year-old expectant mother was admitted under the expert care of Dr. Swatika Kumari, Senior Gynaecologist, after a detailed fetal anomaly scan revealed left-sided CDH with severely hypoplastic lungs.

Recognising the extreme risk of respiratory collapse immediately after birth, the hospital activated its High-Risk Delivery Protocol, ensuring that the Neonatal Intensive Care Unit (NICU) and surgical teams were on standby.

Birth and the Critical Golden Hour

The baby was delivered on November 15, 2025, at 9:16 AM. As anticipated, the newborn presented with severe respiratory distress, a classic indicator of compromised lung development in CDH cases.

Under the leadership of Dr. Ashwin Borade, Senior Pediatrician & Neonatologist, the NICU team initiated rapid resuscitation, advanced ventilation, and hemodynamic stabilisation. The first hour proved crucial, as the team worked swiftly to maintain oxygenation and prevent circulatory collapse.

Within hours, the neonate underwent a comprehensive evaluation to determine surgical readiness—an assessment made more challenging due to fragile lungs and compromised cardiopulmonary dynamics.

Life-Saving Surgical Intervention at 24 Hours of Life

At approximately 24 hours after birth, Dr. Pranav Jadhav, Pediatric Surgeon, performed a critical corrective surgery to reconstruct the diaphragm and reposition herniated abdominal organs.

The procedure required extraordinary precision, given:

1. The newborn’s severely underdeveloped lungs
2. High anaesthesia risk
3. Potential intra-operative instability

Early intervention, coupled with coordinated preparation in the NICU, proved decisive in improving long-term survival chances.

Intensive Post-Operative Care and Steady Recovery

Over the next several days, the newborn remained under continuous NICU monitoring, requiring ventilatory support and vigilant management to prevent complications such as pulmonary hypertension, sepsis, shock, or feeding issues.

NICU nurses and resident doctors provided round-the-clock care, ensuring stabilisation of respiratory and cardiovascular parameters, gradual weaning from the ventilator, and careful initiation of feeds.

During this period, Lactation Consultant Dr. Rani Balgude offered essential support to the mother. Through structured counselling, guided expression technique,s and supervised latching, she facilitated the successful initiation of breastfeeding—an outcome crucial for immunity, growth, and emotional bonding in high-risk neonates.

Discharge and A Story of Hope

On 07/12/2025, the baby was discharged in stable condition, feeding exclusively on breastmilk and showing no post-operative complications.

For the medical team, the moment symbolised the culmination of weeks of dedication and teamwork.

“Cases like this remind us that medicine is not just science—it is teamwork, trust, and compassion. Our NICU team worked around the clock, and watching this little warrior leave the hospital in good health was truly heart-warming,” said Dr. Ashwin Borade, Senior Pediatrician & Neonatologist.

“This successful outcome reinforces how early diagnosis, coordinated preparedness, and multidisciplinary expertise can turn a critical neonatal emergency into a story of survival and hope,” added Dr. Pranav Jadhav, Pediatric Surgeon.

The post Saving a Newborn with Congenital Diaphragmatic Hernia Through Expert Multidisciplinary Care appeared first on NRI News.